New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2013
05:55 EDTAGN, AGN, SE, SE, NYX, NYX, K, K, EL, EL, EMR, EMR, ETN, ETN, DO, DO, DLPH, DLPH, CSC, CSC, CAH, CAH, BDX, BDX, ADP, ADP, ADM, ADM, TE, TECompanies reporting Before the Market Open on Tuesday, February 5
Notable companies reporting before the opening bell include Allergan (AGN), Archer Daniels Midland (ADM), Automatic Data Processing (ADP), Becton Dickinson and Co (BDX), Cardinal Health (CAH), Computer Sciences (CSC), Delphi Automotive (DLPH), Diamond Offshore Drilling (DO), Eaton (ETN), Emerson Electric (EMR), Estee Lauder Companies (EL), Kellogg (K), NYSE Euronext (NYX), Spectra Energy (SE) and TECO Energy (TE).
News For AGN;ADM;ADP;BDX;CAH;CSC;DLPH;DO;ETN;EMR;EL;K;NYX;SE;TE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
June 17, 2015
08:03 EDTCSCRaytheon and CSC sign comprehensive teaming agreement
Subscribe for More Information
07:44 EDTAGNKYTHERA volatility low into Allergan acquiring for approximately $2.1B
Subscribe for More Information
07:21 EDTAGNGeneric ADHD drugs still sold despite FDA non-equivalance finding, NYT reports
The FDA announced last November that two generic versions of Johnson & Johnson's (JNJ) Concerta ADHD drug, one made by Mallinckrodt (MNK) and the other by UCB, could no longer be considered the equivalent of the branded drug after tests and analyses suggested that their effectiveness began to wear off much more quickly, but the drugs are still being sold despite an FDA mandated deadline having passed for the companies to either prove the drugs were equivalent or remove them from the market, said The New York Times. The report noted a third generic product, sold by Actavis (AGN), was found to be equivalent to the branded Concerta. Reference Link
07:15 EDTAGNAllergan to host conference call
Conference call to discuss a definitive agreement to acquire KYTHERA Biopharmaceuticals-(KYTH) will be held at 8:30 am on June 17. Webcast Link
07:04 EDTAGNAllergan to acquire KYTHERA for $75 per share, or $2.1B
Subscribe for More Information
07:03 EDTAGNAllergan agrees to acquire KYTHERA for $75 per share or approximately $2.1B
Subscribe for More Information
07:03 EDTAGNAllergan agrees to acquire KYTHERA for $75 per share or approximately $2.1B
Subscribe for More Information
07:02 EDTAGNAllergan to acquire KYTHERA for $75 per share, or $2.1B
June 16, 2015
10:06 EDTCAHHigh option volume stocks
Subscribe for More Information
09:36 EDTCAHActive equity options trading on open
Subscribe for More Information
09:22 EDTKFDA gives food makers three years to remove partially hydrogenated oils
The FDA announced it has finalized its determination that partially hydrogenated oils, or PHOs, the primary dietary source of artificial trans fat in processed foods, are not “generally recognized as safe” or GRAS for use in human food. Food manufacturers will have three years to remove PHOs from products. In 2013, the FDA made a tentative determination that PHOs could no longer be considered GRAS and is finalizing that determination after considering public comments. The FDA has set a compliance period of three years. This will allow companies to either reformulate products without PHOs and/or petition the FDA to permit specific uses of PHOs. Following the compliance period, no PHOs can be added to human food unless they are otherwise approved by the FDA. Publicly traded food manufacturers include Mondelez (MDLZ), Kraft Foods (KRFT), General Mills (GIS), Hershey (HSY), PepsiCo (PEP), Kellogg (K), ConAgra (CAG) and Campbell Soup (CPB).
08:17 EDTETNEaton says Arnold to succeed Cutler as chairman and CEO on June 1, 2016
Subscribe for More Information
08:16 EDTETNEaton says Alexander Cutler to retire as Chairman and CEO on May 31, 2016
Subscribe for More Information
08:15 EDTETNEaton says Alexander Cutler to retire as Chairman and CEO on May 31, 2016
Subscribe for More Information
08:15 EDTETNEaton board names Craig Arnold president and COO, effective September 1
05:45 EDTAGNAllergan, Richter announce FDA has extended review period for cariprazine
Subscribe for More Information
June 15, 2015
15:35 EDTAGNAllergan CEO says not considering sale of generics unit, Bloomberg reports
Subscribe for More Information
09:53 EDTAGNActavis adopts Allergan as global name, now trading with ticker 'AGN'
Subscribe for More Information
09:16 EDTAGNInternational Parkinson & Movement Disorder Society to hold a conference
9th International Congress of Parkinson's Disease and Movement Disorders is being held in San Diego, CA on June 14-18.
06:58 EDTETNMulti Industry estimates lowered at Credit Suisse
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use